Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
ACS Nano ; 15(11): 17361-17374, 2021 Nov 23.
Artigo em Inglês | MEDLINE | ID: mdl-34662120

RESUMO

Extremely limited drug retention and depigmentation represent the greatest barriers against vitiligo treatment advancement. Here, inspired by biological melanosomes, the primary melanin transporter, we developed biomimetic melanosomes to combat reactive oxygen species (ROS)-mediated melanocyte damage and depigmentation. Briefly, methylprednisolone (MPS) and melanin-mimicking polydopamine (PDA) were encapsulated inside lysine-proline-valine (KPV)-modified deformable liposomes (KPV-Lipos). Owing to their phospholipid bilayer flexibility and the specific affinity for melanocortin 1 receptor (MC1R), KPV-Lipos exhibited 1.43-fold greater skin deposition than traditional liposomes. The binding of KPV and its receptor also contributed to activating the cAMP-tyrosinase (TYR) signaling pathway, improving the endogenous melanin content. In addition, PDA mimicked melanosomes as it effectively increased the exogenous melanin content and scavenged ROS. Meanwhile, MPS inhibited inflammatory cytokine secretion, limiting the depigmented area. Ultimately, the biomimetic melanosomes affected the skin color of mice with H2O2-induced vitiligo. These melanosomes show potential as a universal platform for the self-supply of melanin by self-driven melanin synthesis with exogenous supplementation. Furthermore, this study offers ideas for the production of artificial packed melanosome substitutes for melanocyte-related diseases.


Assuntos
Melanossomas , Vitiligo , Camundongos , Animais , Vitiligo/tratamento farmacológico , Vitiligo/metabolismo , Melaninas , Peróxido de Hidrogênio/metabolismo , Biomimética , Lipossomos/farmacologia , Espécies Reativas de Oxigênio/metabolismo , Melanócitos/metabolismo , Pigmentação
2.
J Mol Neurosci ; 54(4): 591-601, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24752488

RESUMO

Excitotoxicity and cytotoxic edema are the two major factors resulting in neuronal injury during brain ischemia and reperfusion. Ca2+/calmodulin-dependent protein kinase II (CaMK II), the downstream signal molecular of N-methyl-D-aspartate receptors (NMDARs), is a mediator in the excitotoxicity. Aquaporin 4 (AQP4), expressed mainly in the brain, is an important aquaporin to control the flux of water. In a previous study, we had reported that pretreatment of simvastatin protected the cerebrum from ischemia and reperfusion injury by decreasing neurological deficit score and infarct area (Zhu et al. PLoS One 7:e51552, 2012). The present study used a middle cerebral artery occlusion (MCAO) model to further explore the pleiotropic effect of simvastatin via CaMK II and AQP4. The results showed that simvastatin reduced degenerated cells and brain edema while decreasing the protein expressions of phosphor-CaMK II and AQP4, and increasing the ratios of Bcl-2/Bax, which was independent of cholesterol-lowering effect. Immunocomplexes formed between the subunit of NMDARs-NR3A and AQP4 were detected for the first time. It was concluded that simvastatin could protect the cerebrum from neuronal excitotoxicity and cytotoxic edema by downregulating the expressions of phosphor-CaMK II and AQP4, and that the interaction between NR3A and AQP4 might provide the base for AQP4 involving in the signaling pathways mediated by NMDARs.


Assuntos
Aquaporina 4/metabolismo , Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina/metabolismo , Cérebro/metabolismo , Hipolipemiantes/farmacologia , Infarto da Artéria Cerebral Média/metabolismo , Sinvastatina/farmacologia , Animais , Aquaporina 4/genética , Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina/genética , Cérebro/citologia , Cérebro/efeitos dos fármacos , Colesterol/metabolismo , Regulação para Baixo , Hipolipemiantes/uso terapêutico , Infarto da Artéria Cerebral Média/prevenção & controle , Masculino , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Ligação Proteica , Ratos , Ratos Sprague-Dawley , Receptores de N-Metil-D-Aspartato/metabolismo , Sinvastatina/uso terapêutico
3.
Brain Res Bull ; 97: 53-62, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23751198

RESUMO

Studies have revealed that apelin is a novel multifunctional peptide implicated both in blood pressure (BP) regulation and cardiac function control. Evidence shows that apelin and its receptor (APJ) in the rostral ventrolateral medulla (RVLM) may play an important role in central BP regulation; however, its role is controversial and very few reports have shown the relationship between acupuncture and apelin. Our study aims to both investigate the apelinergic system role in stress-induced hypertension (SIH) and determine whether acupuncture therapy effects on hypertension involve the apelinergic system in the RVLM. We established the stress-induced hypertensive rat (SIHR) model using electric foot-shock stressors with noise interventions. The expression of both apelin and the APJ receptor in the RVLM neurons was examined by immunohistochemical staining and Western blots. The results showed apelin expression increased remarkably in SIHR while APJ receptor expression showed no significant difference between control and SIHR groups. Microinjection of apelin-13 into the RVLM of control rats or SIHR produced pressor and tachycardic effects. Furthermore, effects induced by apelin-13 in SIHR were significantly greater than those of control rats. In addition, repetitive electroacupuncture (EA) stimulation at the Zusanli (ST-36) acupoint attenuated hypertension and apelin expression in the RVLM in SIHR; it also attenuated the pressor effect elicited by exogenous apelin-13 microinjection in SIHR. The results suggest that augmented apelin in the RVLM was part of the manifestations of SIH; the antihypertensive effects of EA might be associated with the attenuation of apelin expression and function in the RVLM, which might be a novel role for EA in SIH setting.


Assuntos
Eletroacupuntura , Hipertensão/terapia , Peptídeos e Proteínas de Sinalização Intercelular/metabolismo , Bulbo/metabolismo , Neurônios/metabolismo , Animais , Apelina , Receptores de Apelina , Modelos Animais de Doenças , Hipertensão/etiologia , Hipertensão/metabolismo , Masculino , Ratos , Ratos Sprague-Dawley , Receptores Acoplados a Proteínas G/metabolismo , Estresse Fisiológico
4.
Artigo em Chinês | MEDLINE | ID: mdl-21158042

RESUMO

AIM: To explore effects of Ginsenosides (Rb1, Rg1) on the expression of Bcl-2, Bax in the serum of kidney ischemia/reperfusion inducing apoptosis of HK-2 cells. METHODS: The serum of rabbits with renal ischemia/reperfusion (SIR) and the control serum of rabbits (SC) were acquired and cultured with HK-2 cells. Detected apoptosis with TUNEL assay. The experiment was designed as: control group,ischemia/ reperfusion group, Rb1 blocking group and Rg1 blocking group. To detect the expression of Bcl-2, Bax with immunocytochemistry after 24 hours' cultured. RESULTS: The expression of Bax in Rb1 blocking group and Rg1 blocking group were significantly decreased (P < 0.01), the ratios of Bcl-2/Bax were increased as compared with ischemia/reperfusion group. CONCLUSION: Rb1 and Rg1 have protective effects on apoptosis of HK-2 cells induced by serum of kidney ischemia/reperfusion.


Assuntos
Apoptose/efeitos dos fármacos , Ginsenosídeos/farmacologia , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Traumatismo por Reperfusão/sangue , Proteína X Associada a bcl-2/metabolismo , Animais , Linhagem Celular , Feminino , Isquemia/sangue , Rim/irrigação sanguínea , Túbulos Renais Proximais/citologia , Masculino , Proteínas Proto-Oncogênicas c-bcl-2/genética , Coelhos , Soro/fisiologia , Proteína X Associada a bcl-2/genética
5.
Artigo em Chinês | MEDLINE | ID: mdl-18414699

RESUMO

OBJECTIVE: To investigate the infection of HEV in Quzhou area of Zhejiang Province. METHODS: All sera from blood donors in the central blood bank of Quzhou from April 2006 to April 2007 were used. Anti-HEV IgG and anti-HEV IgM were measured by EIA. RT-PCR was also performed to the samples with positive anti-HEV IgM. Genotype and sequence homology were analyzed after sequencing. RESULTS: The positive ratio of anti-HEV IgG was 40.60%, in which the male infection ratio was higher than the female significantly (43.09% VS 36.09%; chi2=22.6; P < 0.01). The infection ratio was increased with age. The positive ratio of anti-HEV IgM was 0.43%. The positive ratio of anti-HEV IgG and the titers of antibody were higher in the inferior clinical infectors with positive anti-HEV IgM than the negative ones (P < 0.05). Two samples were positive in HEV PCR among 21 samples with positive anti-HEV IgM. The toxemia ratio was 0.4% of all the donors. And the genotype of the two samples with toxemia were both HEV-IV. CONCLUSION: The HEV infection was correlation with age and sex significantly and the infection occurred in the adults mainly in Quzhou area. HEV toxemia was not infrequency in the blood donors.


Assuntos
Doadores de Sangue , Hepatite E/complicações , Hepatite E/epidemiologia , Toxemia/complicações , Toxemia/epidemiologia , Adolescente , Adulto , Fatores Etários , Anticorpos Antivirais/análise , Anticorpos Antivirais/imunologia , China/epidemiologia , Feminino , Genótipo , Hepatite E/imunologia , Hepatite E/virologia , Vírus da Hepatite E/genética , Vírus da Hepatite E/imunologia , Humanos , Imunoglobulina G/análise , Imunoglobulina G/imunologia , Imunoglobulina M/análise , Imunoglobulina M/imunologia , Masculino , Pessoa de Meia-Idade , Análise de Sequência de DNA , Homologia de Sequência , Fatores Sexuais , Toxemia/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA